Recombinant Ashbya gossypii Golgi to ER traffic protein 2 (GET2)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which may serve as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
GET2; ACL036W; Golgi to ER traffic protein 2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-289
Protein Length
full length protein
Species
Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)
Target Names
GET2
Target Protein Sequence
MSEVSEAEKRRILREKRKQKFSKGAGSARLHKITTQQPGGASGDSTVTSAEISDNEGSLQ RGSNSGQSTREIDDLLAAMDPPIEPAEPLESAAPEVAFIQQLMKMQQGSATPPADEKAGG LFSPLLERLAEQEAGGAPVVSGEVGVHQFQVRQLKAYMLLLRWAILLPFIYYVMHPGTAH WLHTSRFLHFVMEPRNFFMVFTTFEVASISIYYQVLLTLERTNKVNSLSYSSKLVTWAGL VPDGMLPIDNLQGKVVVALHYWDILSMYLTDLSLCLVAAGLMKYYHAAP
Uniprot No.

Target Background

Function

Required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum (ER). GET2, in conjunction with GET1, functions as a membrane receptor for soluble GET3. GET3 recognizes and selectively binds the transmembrane domain of TA proteins within the cytosol. The GET complex collaborates with the HDEL receptor ERD2 to facilitate the ATP-dependent retrieval of resident ER proteins, containing a C-terminal H-D-E-L retention signal, from the Golgi apparatus back to the ER.

Database Links
Protein Families
GET2 family
Subcellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein. Golgi apparatus membrane; Multi-pass membrane protein.

Q&A

What is Ashbya gossypii and why is it significant as a model organism?

Ashbya gossypii is a filamentous fungus primarily known for industrial riboflavin (vitamin B2) production. Its significance as a model organism stems from its close phylogenetic relationship to unicellular yeasts like Saccharomyces cerevisiae while exhibiting filamentous growth patterns . This unique positioning makes A. gossypii particularly valuable for studying the regulatory networks that govern morphological differences between filamentous and yeast growth forms.

The fully sequenced A. gossypii genome allows for comparative genomic analyses, facilitating the elucidation of developmental processes relevant to both filamentous fungi and yeasts. This knowledge has potential applications in understanding dimorphic fungi like Candida albicans, where morphological transitions are linked to pathogenicity . Additionally, A. gossypii has emerged as a promising host system for recombinant protein production due to its secretory capacity and genetic tractability .

How is recombinant GET2 protein typically expressed and purified?

Recombinant GET2 protein from Ashbya gossypii is typically expressed using heterologous expression systems, with E. coli being the most common host organism. The basic methodology involves:

  • Gene cloning and vector construction: The full-length GET2 gene (coding for amino acids 1-289) is cloned into an expression vector with an N-terminal His-tag for purification purposes .

  • Expression conditions: The recombinant construct is transformed into E. coli expression strains. Optimal expression conditions typically involve induction with IPTG at reduced temperatures (16-25°C) to enhance proper folding of the protein .

  • Purification strategy: The protein is purified using immobilized metal affinity chromatography (IMAC) via the N-terminal His-tag. Further purification may involve size exclusion chromatography to obtain homogeneous protein preparations .

  • Storage conditions: The purified protein is typically stored in Tris-based buffer containing 50% glycerol at -20°C. For extended storage, -80°C is recommended. Working aliquots can be maintained at 4°C for up to one week, though repeated freeze-thaw cycles should be avoided .

This standardized approach yields functionally active recombinant GET2 protein suitable for biochemical and structural studies.

What expression systems can be used for heterologous production of A. gossypii GET2?

Several expression systems have been utilized for the heterologous production of A. gossypii GET2, each with distinct advantages:

Expression SystemAdvantagesLimitationsApplications
E. coliHigh yield, rapid growth, simple genetic manipulationLack of eukaryotic post-translational modifications, potential inclusion body formationBiochemical studies, structural analyses, antibody production
Saccharomyces cerevisiaeEukaryotic post-translational modifications, proper folding of complex proteinsLower yields than E. coli, longer growth timeFunctional studies, protein-protein interaction analyses
Pichia pastorisHigh-density cultivation, strong promoters, proper protein foldingComplex media requirements, longer development timeLarge-scale production, proteins requiring glycosylation
Insect cellsComplex eukaryotic post-translational modificationsExpensive, technically demandingStructural studies requiring native-like modifications

E. coli remains the most commonly used system for GET2 expression due to its simplicity and high yields, as evidenced by commercial preparations of the recombinant protein . The choice of expression system should be guided by the specific research application and the requirement for post-translational modifications.

How does protein secretion stress affect GET2 function in Ashbya gossypii?

Protein secretion stress in Ashbya gossypii significantly impacts the function of components in the secretory pathway, including GET2. When investigating secretion stress using DTT (dithiothreitol) treatment, which disrupts protein folding in the ER, several important observations regarding potential GET2 involvement emerge:

DTT treatment (10 mM) causes an immediate and substantial reduction in the specific growth rate of A. gossypii cells, with complete growth arrest at earlier time points . This stress response likely affects GET2 function through multiple mechanisms:

  • Transcriptional responses: Though GET2 itself wasn't specifically mentioned in the transcriptome analysis, the secretion stress response activates genes involved in various aspects of protein processing and transport. The correlation analysis between EGI secretion and gene expression indicated that 21 genes were differentially expressed, with enrichment in translation and transmembrane transport processes . As part of the membrane trafficking machinery, GET2 function may be modulated by these transcriptional changes.

  • Functional impairment: Under secretion stress, protein folding is compromised, potentially leading to mislocalization of tail-anchored proteins that normally depend on the GET pathway. This may result in altered GET2 function as the cell attempts to adapt to the stress condition.

  • Compensatory mechanisms: The ER-associated degradation (ERAD) pathway is often upregulated under secretion stress conditions, which may interact with GET2 function to clear misfolded proteins from the secretory pathway.

Methodologically, studying GET2 function under secretion stress would require combining transcriptomic approaches with localization studies using fluorescently tagged GET2 and its interaction partners, coupled with functional assays for protein trafficking efficiency.

What promoter systems are optimal for expression of GET2 or other secretory pathway components in A. gossypii?

The optimization of promoter systems for expressing GET2 or other secretory pathway components in A. gossypii requires careful consideration of expression strength, regulation, and timing. Recent advancements in A. gossypii molecular toolbox development provide valuable insights:

For effective expression of secretory pathway components like GET2, several promoter options with distinct characteristics are available:

The molecular toolbox for A. gossypii has been expanded through the adaptation of the Dual Luciferase Reporter (DLR) Assay using integrative cassettes, which allows precise quantification of promoter strength in the multinucleated syncytium of A. gossypii . This system improves experimental accuracy compared to plasmid-based methods, which suffer from instability in A. gossypii.

For GET2 expression, the optimal promoter choice would depend on the research objective:

  • For complementation studies: moderate promoters like P<sub>TSA1</sub> would maintain near-physiological expression levels

  • For overexpression to analyze trafficking effects: strong promoters like P<sub>CCW12</sub> would maximize protein production

  • For inducible expression: carbon source-responsive promoters would enable temporal control

These new promoter tools significantly expand the options for genetic engineering of A. gossypii for both fundamental research and biotechnological applications .

How does GET2 interact with the regulatory networks that control nuclear division in multinucleated A. gossypii cells?

The interaction between GET2 and the regulatory networks controlling nuclear division in multinucleated A. gossypii cells represents a complex research area at the intersection of membrane trafficking and cell cycle regulation. While direct evidence for GET2 involvement in nuclear division isn't explicitly stated in the provided search results, several potential connections can be hypothesized based on the known biology of A. gossypii:

A. gossypii exhibits asynchronous nuclear division within its multinucleated hyphal cells, with mitoses concentrated near cortical septin rings at growing tips and branchpoints . This spatial regulation of mitosis involves septin proteins and the AgSwe1p kinase pathway, which responds to both morphogenesis cues and nutrient availability .

Potential interactions between GET2 and nuclear division regulation may occur through:

  • Membrane dynamics during cell growth: GET2's role in Golgi-to-ER trafficking may influence membrane composition and dynamics at growing hyphal tips, potentially affecting the localization or function of the septin rings that spatial direct mitosis.

  • Nutrient sensing pathways: Under starvation conditions, A. gossypii shows AgSwe1p-dependent tyrosine phosphorylation of CDK, resulting in diminished nuclear density . The secretory pathway, including GET2, might participate in the cellular response to nutrient limitation by regulating the trafficking of nutrient sensors or signaling components.

  • ER stress signaling: Disruptions in GET2 function could potentially trigger ER stress responses, which might cross-talk with cell cycle regulatory pathways, including those controlled by AgSwe1p.

Experimentally investigating these connections would require sophisticated approaches combining:

  • Conditional GET2 mutants to analyze effects on nuclear division patterns

  • Co-localization studies of GET2 with septin structures and cell cycle regulators

  • Phosphoproteomic analyses under GET2 depletion or overexpression conditions

  • Epistasis analyses with mutations in AgSwe1p pathway components

This research direction could reveal novel connections between membrane trafficking and nuclear division control in multinucleated cells.

What is the role of GET2 in the secretory capacity of A. gossypii for biotechnological applications?

The role of GET2 in the secretory capacity of A. gossypii has significant implications for biotechnological applications, particularly in the context of using this organism as a platform for recombinant protein production and metabolite biosynthesis.

A. gossypii has emerged as a versatile platform for producing various compounds including riboflavin, sabinene, and other valuable metabolites . The secretory pathway, of which GET2 is a component, plays a critical role in these applications:

  • Recombinant protein secretion: GET2, as part of the GET complex responsible for tail-anchored protein insertion into the ER membrane, likely influences the proper localization of key components of the secretory machinery. This function becomes crucial when A. gossypii is engineered to secrete heterologous proteins like endoglucanase I (EGI) . Optimization of GET2 expression or function could potentially enhance secretory capacity.

  • Metabolite production: In engineered A. gossypii strains producing compounds like sabinene (reaching levels of 684.5 mg/L) , secretory pathway efficiency affects both cell viability and product export. GET2's role in maintaining ER homeostasis may indirectly impact the cell's ability to handle the metabolic burden of overproduction.

  • Stress response management: When A. gossypii is subjected to secretion stress (e.g., during heterologous protein production), the cellular response includes changes in gene expression related to transmembrane transport . Understanding and potentially modifying GET2 function could help mitigate these stress responses.

Methodological approaches to investigate and optimize GET2's contribution would include:

  • Creation of GET2 variant libraries with altered expression levels or protein sequences

  • Integration with metabolic engineering strategies, particularly when targeting production of compounds that interact with cellular membranes

  • Proteomic profiling of secretory pathway components under different production conditions

  • Adaptive laboratory evolution coupled with GET2 variant screening to identify beneficial mutations

The development of new promoter systems for A. gossypii offers additional tools to fine-tune GET2 expression in biotechnological applications, potentially enhancing product yields through optimized secretory pathway function.

How can structural studies of A. gossypii GET2 inform the design of improved protein trafficking systems?

Structural studies of A. gossypii GET2 can significantly inform the design of improved protein trafficking systems through detailed characterization of protein-protein interactions, membrane integration mechanisms, and species-specific adaptations in the GET pathway. While no specific structural data for A. gossypii GET2 is provided in the search results, a methodological approach to this question can be outlined:

The 289-amino acid sequence of A. gossypii GET2 provides the foundation for structural analyses through:

  • Comparative structural modeling: Using the known structures of GET2/Rmd7 from other organisms (particularly S. cerevisiae) as templates, homology models of A. gossypii GET2 can be generated to predict its tertiary structure. Key regions for analysis include:

    • The N-terminal cytosolic domain (approximately residues 1-140)

    • The C-terminal transmembrane region (approximately residues 141-289)

    • Putative interaction interfaces with GET1 and GET3

  • Functional domain mapping: Structure-guided mutagenesis can identify critical residues for:

    • GET complex assembly

    • Substrate recognition

    • Membrane integration efficiency

    This approach would involve systematic alanine scanning or domain swapping experiments followed by functional assays for protein trafficking.

  • Species-specific adaptations: Structural comparisons between A. gossypii GET2 and its homologs in other fungi like S. cerevisiae or C. albicans may reveal adaptations specific to filamentous growth or specialized secretory requirements. These insights could guide the engineering of GET pathway components optimized for specific applications.

  • Design of synthetic trafficking modules: Based on structural understanding, engineered variants of GET2 with altered specificity, efficiency, or regulation could be designed to:

    • Enhance secretion of specific protein classes

    • Reduce ER stress during high-level protein production

    • Create inducible trafficking controls

The recombinant GET2 protein available as research tools provides the material basis for these structural studies, which could employ X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy depending on the specific research questions.

By elucidating the structure-function relationships in GET2, researchers can rationally design improved trafficking systems that enhance A. gossypii's utility as a production platform for proteins and metabolites.

What methodologies can be used to study the interaction network of GET2 in A. gossypii's secretory system?

Investigating the interaction network of GET2 in A. gossypii's secretory system requires sophisticated methodological approaches that account for the organism's filamentous morphology and multinucleated nature. The following comprehensive strategies can be employed:

  • Proximity-based proteomics approaches:

    • BioID or TurboID: Fusing GET2 with a promiscuous biotin ligase to biotinylate proximal proteins, followed by streptavidin pulldown and mass spectrometry

    • APEX2 proximity labeling: Using ascorbate peroxidase fusions to GET2 for spatially restricted protein labeling

    These methods are particularly valuable in A. gossypii as they capture transient interactions within the native cellular context of the hyphal cells.

  • Affinity purification coupled with mass spectrometry (AP-MS):

    • Tandem affinity purification (TAP) tagging of GET2 using the established molecular toolbox for A. gossypii

    • CRISPR/Cas9-mediated endogenous tagging to maintain physiological expression levels

    • Cross-linking-assisted immuno-precipitation to stabilize transient interactions

  • Genetic interaction mapping:

    • Synthetic genetic array (SGA) analysis adapted for A. gossypii to identify genes that exhibit synthetic lethality or suppression with GET2 mutations

    • CRISPR interference (CRISPRi) screens to identify genes whose depletion phenotypes are exacerbated or suppressed by GET2 perturbation

  • Advanced microscopy techniques:

    • Multi-color live cell imaging using the Dual Luciferase Reporter system framework adapted for fluorescent protein expression

    • FRET/FLIM analyses for direct visualization of protein-protein interactions in living hyphae

    • Super-resolution microscopy to precisely localize GET2 relative to other secretory components

  • Functional reconstitution assays:

    • In vitro reconstitution of the GET pathway using purified components including recombinant A. gossypii GET2

    • Liposome-based trafficking assays to measure insertion efficiency of tail-anchored proteins

  • Computational network inference:

    • Integration of proteomics data with transcriptomics results from secretion stress experiments

    • Comparative analysis with known interaction networks from model yeasts like S. cerevisiae

Implementation of these methodologies would benefit from the molecular tools developed for A. gossypii, including integrative expression cassettes, various promoter options , and recombinant protein production capabilities . The multinucleated nature of A. gossypii presents unique challenges but also opportunities to study how protein interaction networks function across shared cytoplasm, potentially revealing novel regulatory mechanisms specific to filamentous fungi.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.